Published in J Exp Med on May 01, 1994
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest (2001) 2.26
B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med (2002) 2.01
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. Blood (2015) 1.55
B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med (1999) 1.55
B-1 B cell development in the fetus and adult. Immunity (2012) 1.47
Nature and functions of autoantibodies. Nat Clin Pract Rheumatol (2008) 1.43
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A (1995) 1.27
An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system. J Exp Med (2005) 1.20
Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation. J Clin Invest (1997) 1.15
Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice. J Immunol (2013) 1.12
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes. Proc Natl Acad Sci U S A (2000) 1.01
Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. J Immunol (2006) 1.00
Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol Immunol (2009) 0.99
Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med (1999) 0.98
Human B-1 cells take the stage. Ann N Y Acad Sci (2013) 0.97
Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc (2010) 0.97
Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci U S A (2003) 0.97
The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. EMBO J (1996) 0.96
Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun (2006) 0.95
VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol (1997) 0.95
Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection. PLoS One (2010) 0.94
Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction. J Immunol (2015) 0.93
Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes. Clin Exp Immunol (2004) 0.91
Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J Exp Med (1999) 0.90
Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood (2006) 0.90
IgA response in preterm neonates shows little evidence of antigen-driven selection. J Immunol (2012) 0.90
Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc Natl Acad Sci U S A (2012) 0.87
B1b cells recognize protective antigens after natural infection and vaccination. Front Immunol (2014) 0.86
A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF. Front Immunol (2011) 0.86
Btk regulates multiple stages in the development and survival of B-1 cells. Mol Immunol (2007) 0.85
Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells. Nat Immunol (2017) 0.85
Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82
CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol Immunol (2009) 0.82
Role of B cell receptor signaling in IL-10 production by normal and malignant B-1 cells. Ann N Y Acad Sci (2015) 0.79
Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy. Autoimmun Rev (2012) 0.77
Receptor cross-talk spatially restricts p-ERK during TLR4 stimulation of autoreactive B cells. J Immunol (2012) 0.77
Fetal Lymphoid Progenitors Become Restricted to B-1 Fates Coincident with IL-7Rα Expression. PLoS One (2016) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (1988) 9.17
Construction of coliphage lambda Charon vectors with BamHI cloning sites. Gene (1980) 5.83
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
5' flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell (1980) 4.62
Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 4.16
Origin of murine B cell lineages. Annu Rev Immunol (1993) 3.82
The Ly-1 B cell lineage. Immunol Rev (1986) 3.59
Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50
Molecular and cellular events of T cell development. Adv Immunol (1989) 3.50
Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60
The CD5 B cell. Adv Immunol (1989) 2.49
Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol (1986) 2.30
Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med (1992) 2.15
Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol (1992) 2.15
A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J Immunol (1989) 2.05
A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A (1991) 1.96
Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol (1991) 1.90
All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol (1990) 1.82
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Rearrangement and selection of VH11 in the Ly-1 B cell lineage. J Exp Med (1990) 1.54
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Clonal deletion of autospecific B lymphocytes. Immunol Rev (1991) 1.42
Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci (1992) 1.36
B-1 cells are made, not born. Immunol Today (1993) 1.32
B-cell lineages exist in the mouse. Immunol Today (1993) 1.30
A member of a new VH gene family encodes antibromelinized mouse red blood cell autoantibodies. Eur J Immunol (1988) 1.28
The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol (1990) 1.25
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
A new nomenclature for B cells. Immunol Today (1991) 1.13
Organization and expression of VH gene families preferentially expressed by Ly-1+ (CD5) B cells. Eur J Immunol (1989) 1.01
Surface markers, heavy chain sequences and B cell lineages. Int Rev Immunol (1992) 1.00
Predominance of nonproductive rearrangements of VH81X gene segments evidences a dependence of B cell clonal maturation on the structure of nascent H chains. J Immunol (1991) 0.97
Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci (1992) 0.89
Lymphocyte survival and V-region repertoire selection. Immunol Today (1993) 0.87
Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int Immunol (1993) 0.83
VH CDR3-dependent positive selection of murine VH12-expressing B cells in the neonate. Eur J Immunol (1993) 0.83
Contribution of the CD5+ B cell to D-proximal VH family expression early in ontogeny. J Immunol (1990) 0.81
Diversity in the available repertoire of murine antibodies reactive with bromelain-treated isologous erythrocytes. J Immunol (1989) 0.79
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity (1996) 1.54
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med (1986) 1.33
V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J Immunol (1993) 1.32
B-1 cells are made, not born. Immunol Today (1993) 1.32
Polymorphism in immunoglobulin heavy chains suggesting gene conversion. Proc Natl Acad Sci U S A (1982) 1.24
Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families. J Exp Med (1983) 1.21
Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res (2001) 1.21
Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity (1998) 1.18
Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol (1993) 1.16
Evidence for gene conversion among immunoglobulin heavy chain variable region genes. J Exp Med (1984) 1.05
Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms. J Pediatr (1984) 1.02
Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine. J Immunol (1988) 1.01
Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J Immunol (1996) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
Organization and expression of VH gene families preferentially expressed by Ly-1+ (CD5) B cells. Eur J Immunol (1989) 1.01
Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur J Immunol (1986) 1.00
Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J Immunol (2001) 0.98
Sm and DNA binding by dual reactive B cells requires distinct VH, V kappa, and VH CDR3 structures. J Immunol (1995) 0.96
The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. EMBO J (1996) 0.96
Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell Immunol (2001) 0.94
Interdependence of N nucleotide addition and recombination site choice in V(D)J rearrangement. J Immunol (1996) 0.93
A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J Immunol (2001) 0.91
High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J Immunol Methods (1997) 0.90
Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J Immunol (2001) 0.89
The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol (1995) 0.88
Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines. J Immunol (1993) 0.88
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. J Mol Cell Immunol (1987) 0.87
An in vitro model for toxin-mediated vascular leak syndrome: ricin toxin A chain increases the permeability of human endothelial cell monolayers. Blood (1997) 0.86
Mechanisms that limit the diversity of antibody: three sequentially acting mechanisms that favor the spontaneous production of germline encoded anti-phosphatidyl choline. Int Immunol (1993) 0.83
Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C. J Biol Chem (1997) 0.83
VH CDR3-dependent positive selection of murine VH12-expressing B cells in the neonate. Eur J Immunol (1993) 0.83
Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82
Identification of a highly conserved module in E proteins required for in vivo helix-loop-helix dimerization. J Biol Chem (1998) 0.82
Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments. J Immunol (1984) 0.82
Biocompatibility of Trillium Biopassive Surface-coated oxygenator versus uncoated oxygenator during cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2001) 0.82
Influence of VH CDR3 arginine and light chain pairing on DNA reactivity of a bacterial DNA-induced anti-DNA antibody from a BALB/c mouse. J Immunol (1997) 0.81
Restriction in V kappa gene use and antigen selection in anti-myeloperoxidase response in mice. J Immunol (2000) 0.80
STAT3 activation, chemokine receptor expression, and cyclin-Cdk function in B-1 cells. Curr Top Microbiol Immunol (2000) 0.79
Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. Cancer Res (1995) 0.79
Antibodies specific for Ig idiotype, but not isotype, can substitute for antigen to induce IgM secretion by a B cell clone. Int Immunol (1990) 0.78
Construction and characterization of human CD7-specific single-chain Fv immunotoxins. J Immunol (1997) 0.78
The majority of murine VH12-expressing B cells are excluded from the peripheral repertoire in adults. Eur J Immunol (1995) 0.78
Laboratory preparation of a deglycosylated ricin toxin A chain containing immunotoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies. J Immunol Methods (1996) 0.78
Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome. J Pediatr (1989) 0.77
In vitro studies of ricin A-chain-induced vascular leak syndrome. Methods Mol Biol (2001) 0.77
The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage. Eur J Immunol (1994) 0.77
T cell autoimmunity in Ig transgenic mice. J Immunol (1999) 0.77
Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol (1996) 0.77
Bacterial expression and characterization of an anti-desipramine single-chain antibody fragment. Int J Immunopharmacol (1996) 0.76
Differential susceptibility to tolerance induction in vitro of splenic B cells from several transgenic mouse lines. Role of B1 cells. J Immunol (1995) 0.76
Transurethral resection of bladder growths. Acta Urol Belg (1969) 0.75
An institution-specific heparin titration nomogram: development, validation, and assessment of compliance. Pharmacotherapy (2001) 0.75
Models and mechanisms for signal transduction in B cells. Immunol Res (1986) 0.75
Visualization of immunotoxin-mediated tumor cell death in vivo. Clin Cancer Res (2001) 0.75
Trauma to the urinary tract. Br Med J (1971) 0.75
Adrenalectomy and coat color in deer mice. Science (1966) 0.75
Brodifacoum intoxication with marijuana smoking. Arch Pathol Lab Med (1997) 0.75
The CH series of murine B cell lymphomas: identification of cross-reactive idiotypes and restricted antigen specificities. Curr Top Microbiol Immunol (1984) 0.75
Late holocene tectonics and paleoseismicity, southern cascadia subduction zone. Science (1992) 0.75
Selective maturation of VH12 B cells in the spleen enriches for anti-phosphatidyl choline B cells: evidence for receptor editing. Curr Top Microbiol Immunol (2000) 0.75